C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2011
08/30/2011	US8007816 Yeast-based therapeutic for chronic hepatitis C infection
08/30/2011	US8007805 Chimeric antigens for breaking host tolerance to foreign antigens
08/30/2011	US8007800 Methods for treating bone cancer pain by administering a nerve growth factor antagonist antibody
08/30/2011	US8007798 Treatment of complement-associated disorders
08/30/2011	US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/30/2011	CA2288962C Human monoclonal antibodies to epidermal growth factor receptor
08/30/2011	CA2277561C Intracellular selection
08/30/2011	CA2190473C Recombinant papilloma virus l1
08/25/2011	WO2011103453A2 Vaccines for use in the prophylaxis and treatment of influenza virus disease
08/25/2011	WO2011103325A1 Methods for preparing human growth hormone
08/25/2011	WO2011103248A2 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE
08/25/2011	WO2011103247A2 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use
08/25/2011	WO2011103172A1 Compositions and methods for the detection of antibodies to native human leukocyte antigen
08/25/2011	WO2011102556A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102555A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102554A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102553A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102552A1 Antibody against a band lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102551A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102517A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide
08/25/2011	WO2011102342A1 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier
08/25/2011	US20110209230 Human Monoclonal Antibodies To Programmed Death Ligand 1 (PD-L1)
08/25/2011	US20110209229 Gene of porcine beta casein, a promoter of the same and the use thereof
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207913 Induction of Gene Expression Using a High Concentration Sugar Mixture
08/25/2011	US20110207912 Fgf-19 nucleic acids
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207676 Glycosylation of Molecules
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207211 Expression of immunoglobulin-cytokine fusion proteins in malignant b cells
08/25/2011	US20110207175 Multi-culture bioreactor system
08/25/2011	US20110207174 Peptide-containing culture medium for culturing animal cell
08/25/2011	US20110207173 Self-Replicating Vector Lacking An Antibiotic-Resistance Gene
08/25/2011	US20110207171 Oligosaccharide modification and labeling of proteins
08/25/2011	US20110207165 Small scale shaker flask cultivation
08/25/2011	US20110207117 Generation of production strains that efficiently express nuclear transgenes
08/25/2011	US20110206700 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206678 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/25/2011	US20110206677 Antibodies specific for sclerostin and methods for increasing bone mineralization
08/25/2011	US20110206675 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
08/25/2011	US20110206663 Anti-Interferon-Alpha Antibodies
08/25/2011	US20110206616 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2782448A1 Compositions and methods for the detection of antibodies to native human leukocyte antigen
08/24/2011	EP2360473A1 Compositions and methods for analyzing protein interactions
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2359864A2 Targeting Vector-Phospholipid Conjugates
08/24/2011	EP2359849A1 Combination therapy
08/24/2011	EP2359847A1 Modulation of beta-amyloid levels by beta-secretase bace2
08/24/2011	EP2359685A1 Methods to engineer mammalian-type carbohydrate structures
08/24/2011	EP2358392A1 Antibody formulation
08/24/2011	EP1745072B1 Method for producing soluble mhc proteins
08/24/2011	EP1697411B1 Process for purifying interferon beta
08/24/2011	EP1587923B1 Improved constructs for expressing lysosomal polypeptides
08/24/2011	EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
08/24/2011	EP1369426B1 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
08/24/2011	EP1025121B1 Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
08/24/2011	EP0981618B2 Anti-apo-2 antibody
08/24/2011	EP0754059B2 Methods and compositions useful for inhibition of angiogenesis
08/24/2011	CN1954074B Process for producing polypeptides
08/24/2011	CN1906307B Methods for purifying pertussis toxin and peptides useful therefor
08/24/2011	CN102162004A Preparation method of various small molecule activated peptides converted from special biological fungi for EFD (Engineered Fluid Dispensing)
08/24/2011	CN102161999A Efficient solubility expressing method of recombined cysticercus cellulosae specific antigen cC1
08/24/2011	CN102160549A Compound pesticide containing cyprodinil and ningnanmycin
08/24/2011	CN101613735B Method for preparing organic polypeptide
08/24/2011	CN101613733B Method for preparing feather polypeptide
08/24/2011	CN101550186B Sheep recombination prion protein and monoclonal antibody thereof and application
08/24/2011	CN101525628B Processes for preparing heterologous proteins in prokaryotic host cells
08/24/2011	CN101503466B Birdsfoot trefoil root flower type and inflorescence structure regulating protein, preparation and use thereof
08/24/2011	CN101240291B Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof
08/24/2011	CN101100663B Preparing method for recombinant human anti-rabies monoclonal antibodies
08/23/2011	US8003847 Animal models comprising mutation in opoid receptor for use in identifying modulator for prevention and treatment of cell proliferative, nervous system and psychological disorders
08/23/2011	US8003775 Expression vector comprising nucleotide sequences coding streptococcal surface protein for use in detection, prevention and treatment of microorganismal infection
08/23/2011	US8003774 Immunoglobulin variat for use in diagnosis, prevention and treatment of infection, nervous system, skin, inflammatory and cell proliferative diseases
08/23/2011	US8003766 Monoclonal antibody specific to ochratoxin A
08/23/2011	US8003763 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4
08/23/2011	US8003761 Cancerous disease modifying antibodies
08/23/2011	US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
08/23/2011	US8003613 Methods and compositions for inducing apoptosis
08/23/2011	US8003607 HGF precursor protein variant and active protein thereof
08/23/2011	US8003386 Tumor necrosis factor receptors 6α and 6β
08/23/2011	US8003384 Cell lines comprising sour-taste receptors
08/23/2011	US8003382 Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof
08/23/2011	US8003367 Transgenic microorganism comprising xylose operon for use as bioreactor in fermentation of trytophan, histidine, threonine, lysine and/or glutamic acid for use in medicine, cosmetics and animal feeds
08/23/2011	US8003362 Methods and constructs for high yield expression of clostripain
08/23/2011	US8003351 Activatable recombinant neurotoxins
08/23/2011	US8003350 Mutant firefly luciferase, gene, recombinant vector, transformant, and method for production of mutant firefly luciferase
08/23/2011	US8003349 YLMPO1 gene derived from yarrowia lipolytica and a process for preparing a glycoprotein not being mannosylphosphorylated by using a mutated yarrowia lipolytica in which YLMPO1 gene is disrupted
08/23/2011	US8003348 Method for the mass expression of an antimicrobial peptide by co-expression of a basic antimicrobial peptide and an acidic peptide using a translational coupling system

1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 1125